-
Oct 26, 2011:
Continued strong revenue and EBITDA growth and successful launch of EmbryoGen®
Read the press release, Q3 2011 presentation and report
-
Oct 25, 2011:
EmbryoGen: Live birth rates
-
Oct 17, 2011:
Invitation – Q3 2011 presentation
-
Oct 03, 2011:
ORIGIO completes acquisition of Artworks B.V.
-
Aug 31, 2011:
Major shareholder announcement 310811
-
Aug 31, 2011:
Registration of new share capital
-
Aug 29, 2011:
Major shareholder announcement
-
Aug 29, 2011:
ORIGIO completes offering of 2,650,000 new shares
-
Aug 29, 2011:
ORIGIO offers up to 2,650,000 new shares in a private placement at market price
-
Aug 23, 2011:
Organic growth of 22% in 1H 2011 and launch of EmbryoGen®
Read the press release, Q2 2011 presentation and report
-
Aug 19, 2011:
Invitation – Q2 2011 presentation
-
Aug 11, 2011:
EmbryoGen® receives European regulatory approval
-
Jul 08, 2011:
Share issue completed
-
Jul 01, 2011:
New employee representatives on the Board of Directors
-
Jun 30, 2011:
Share issue in connection with a private placement to primary insiders
-
Jun 30, 2011:
ORIGIO progresses with acquisition of Artworks BV
-
Jun 30, 2011:
Launch of EmbryoGen®
-
Jun 30, 2011:
Transfer of own shares
-
May 31, 2011:
ORIGIO expands its product offering for the IVF market
has signed a share purchase agreement with the Dutch manufacturer of IVF oocyte retrieval needles and embryo transfer catheters, Artworks B.V. (“Artworks”) concerning the acquisition of all its shares as of July 1, 2011.
-
May 31, 2011:
Presentation at SEB Enskilda's Small Cap Seminar
-
Apr 29, 2011:
Minutes of Annual General Meeting 2011
-
Apr 28, 2011:
Presentation at Annual General Meeting 2011
Open the pdf file
-
Apr 28, 2011:
Organic growth of 25% in Q1 2011
Read the press release, Q1 2011 presentation and report
-
Apr 27, 2011:
INVITATION – Q1 2011 presentation
Thursday, April 28, 2011 at 10.30 – 11.30
-
Apr 18, 2011:
Annual overview 2010
-
Apr 15, 2011:
Follow-up and further clarifications in relation to the upcoming General Meeting
-
Apr 15, 2011:
Trading update
-
Apr 06, 2011:
Election of the Nomination Committee
-
Apr 06, 2011:
Nomination Committee's Proposal 2011
-
Apr 05, 2011:
Purchase of shares by utilization of warrants
-
Apr 05, 2011:
Purchase of shares by utilization of warrants
-
Mar 29, 2011:
Company presentation at DnB NOR Markets SME-Summit 2011
-
Mar 29, 2011:
Securing the base for further profitable growth
ORIGIO a/s announced today that the Board of Directors will seek authorization at the Annual General Meeting on April 28, 2011, to increase the share capital and accomplish a dual-listing of the Company’s shares on NASDAQ OMX Copenhagen.
-
Mar 29, 2011:
Notice to Annual General Meeting in ORIGIO
The Annual General Meeting will take place on Thursday, April 28, 2011 at 12:00 – 14:00 o’clock at Felix Konferansesenter, Bryggetorget 3, 0125 Oslo, Norway
-
Feb 23, 2011:
Organic growth of 21% in Q4 2010 and positive results for GM-CSF study
Read the press release, Q4 2010 presentation and report
-
Feb 17, 2011:
Invitation – Q4 2010 presentation
Wednesday, February 23, 2011 at 12.00 – 13.00
-
Feb 03, 2011:
PROinvestors Biotech&Medtech seminar
-
Jan 19, 2011:
Financial Calendar 2011
-
Jan 12, 2011:
Successful closing of asset purchase agreement with Incept BioSystems, Inc.